Human cytosolic phenylalanyl-tRNA synthetase (hcPheRS) is responsible for the covalent attachment of phenylalanine to its cognate tRNA Phe . Significant differences between the amino-acid sequences of eukaryotic and prokaryotic PheRSs indicate that the domain composition of hcPheRS differs from that of the Thermus thermophilus analogue. As a consequence of the absence of the anticodon-recognizing B8 domain, the binding mode of tRNA Phe to hcPheRS is expected to differ from that in prokaryotes. Recombinant hcPheRS protein was purified to homogeneity and crystallized. The crystals used for structure determination diffracted to 3.3 Å resolution and belonged to space group C2, with unit-cell parameters a = 362.9, b = 213.6, c = 212.7 Å , = 125.2 . The structure of hcPheRS was determined by the molecular-replacement method in combination with phase information from multiwavelength anomalous dispersion.
Introduction
Over 100 molecules are directly involved in translation of the genetic code; thus, the progress and efficiency of translation depend on the fine coordination of a large variety of interactions. Among the components of the translational machinery are aminoacyl-tRNA synthetases (aaRSs), which are enzymes that play a key role in protein biosynthesis, catalyzing the aminoacylation of tRNAs with their corresponding amino acids. The attachment of the correct amino acid to tRNA by its synthetase is critical to the fidelity of the translation process.
Human cytoplasmic phenylalanyl-tRNA synthetase (hcPheRS) is one of the most complex and the largest enzymes in the aaRS family (for a review, see Safro et al., 2005) . hcPheRS is a heterotetramer with () 2 subunit architecture: each dimer is composed of -subunits and -subunits consisting of 508 and 589 amino acids, respectively (Moor et al., 2002) . Phylogenetic and structural analysis suggests that there are three major forms of PheRS: (i) heterodimeric () 2 bacterial, (ii) heterodimeric () 2 archaeal/eukaryotic cytosolic and (iii) monomeric mitochondrial. The heterotetrameric subunit organization of both prokaryotic and eukaryotic cytoplasmic PheRSs is conserved in all species for which sequences are available. However, heterotetrameric organization is not a prerequisite for phenylalanylation activity, as human monomeric mitochondrial PheRS is also active and its structure has been determined recently at 2.2 Å resolution (Klipcan et al., 2008) . Thus, eukaryotic cells harbour two different types of PheRSs: cytoplasmic and mitochondrial. The subunit organization of the two enzymes shows marked differences and the binding and recognition modes of the cognate tRNA Phe s presumably also differ sharply.
Multiple sequence alignments provide evidence that the polypeptide chains of eukaryotic aaRSs are significantly longer then those of homologous prokaryotic enzymes (Mirande, 1991) . Moreover, numerous observations have indicated that elongation of the chains occurs mostly at the N-or C-terminal extremities of the subunits rather than by insertions into the catalytic domain. The sequence of the hcPheRS catalytic -subunit obeys this rule of thumb: it is $160 residues longer than the respective prokaryotic analogue, whereas the -subunit turns out to be $200 residues shorter (Moor et al., 2002) . Multiple sequence alignments clearly outline regions in the -subunit that are involved in the formation of the active site, thereby confirming that the human -subunit is indeed catalytic, with general features characteristic of class II aaRSs (Ibba & Soll, 2000) .
Although structurally hcPheRS belongs to the class II aaRSs, functionally it resembles class I aaRSs, aminoacylating the 2 0 -OH group of the tRNA terminal ribose. The structure of Thermus thermophilus PheRS (Mosyak et al., 1995) complexed with cognate tRNA Phe demonstrates that one tRNA Phe molecule interacts with all four subunits of the enzyme, thus accounting for the enzyme's activity as a functional () 2 heterotetramer. In bacterial PheRS, recognition and binding of the anticodon triplet of tRNA is mediated by the B8 anticodon-binding domain (RNP) from the -subunit (Goldgur et al., 1997) . In hcPheRS, however, no analogues of the RNP domain have been identified in the amino-acid sequence of the -subunit (Rodova et al., 1999) . This finding led to the suggestion that the binding and recognition modes of cognate tRNA Phe differ between prokaryotes and eukaryotes. Together with its canonical aminoacylation and editing functions, hcPheRS also possesses some additional functions. For instance, it is responsible for the synthesis and turnover of diadenosine tetraphosphate (Ap 4 A), which plays an important role in the response of both bacterial and eukaryotic cells to a variety of stress conditions (Lee et al., 1983) . A human mRNA preferentially expressed in human tumorigenic acute-phase chronic myelogenous leukaemia (CML) K562 cells encodes a polypeptide chain identical to the catalytic -subunit of hcPheRS (Rodova et al., 1999; Sen et al., 1997) . This is an example of tumour-selective and cell-cycle stage-and differentiation-dependent expression of an aaRS-family member in mammalian cells. The insights provided by structural studies will shed light on the novel amino-acid specificity mode of tRNA Phe binding to human hcPheRS and the activities of the enzyme. Here, we report the crystallization, X-ray analysis and molecular-replacement studies of hcPheRS and we highlight interesting characteristics of the molecular packing within the crystal asymmetric unit.
Materials and methods

Expression and purification
The two subunits of hcPheRS were cloned into two different plasmids: the -subunit (residues 1-508) was cloned into a pET-21b(+) vector and the -subunit (residues 1-589) was cloned into a pET-28b(+) vector (Novagen, Germany; Rodova et al., 1999) . The presence of a His tag appended to the N-terminus of the -subunit completely abolished the aminoacylation activity of hcPheRS; therefore, no purification tag was used. These two plasmids were cotransformed into Escherichia coli strain BLR(DE3) (Novagen, Germany). The purification protocol for the nontagged hcPheRS heterotetramer (247 kDa) containing two -subunits and two -subunits consisted of five steps. Ammonium sulfate fractionation was followed by four chromatography columns: anion exchange on a DEAE-Sepharose (Amersham Pharmacia Biotech, USA) column (180 ml volume), a heparin-Sepharose CL-6B column (Pharmacia Biotech USA; volume 15 ml), concentrating the protein on a 1 ml TSK hydrophobic interaction column (Tosoh, Japan) and finally gel filtration on a column (0.9 Â 45 cm) of superfine Sephadex G-200 (Amersham Pharmacia Biotech, USA; for details, see Moor et al., 2002) .
Substitution of the methionines in hcPheRS (15 in the -subunit and 12 in the -subunit) by selenomethionines (Se-hcPheRS) was carried out as described by Van Duyne et al. (1993) . The protocol used for the purification of Se-hcPheRS was similar to that employed for the native protein (Moor et al., 2002) .
Crystallization
Initial crystallization conditions were identified using solutions from Crystal Screens I and II, Index Screen, Cryo Screen, SaltRx (Hampton Research, USA) and PACT Suite (Qiagen, Germany). The microbatch method, performed on an ORYX robot (Douglas Instruments Ltd, London, England; Chayen et al., 1990 Chayen et al., , 1992 , and the hanging-drop vapour-diffusion method were applied. All crystallization experiments were performed at 293 K. hcPheRS was concentrated to 2.29 mg ml À1 in 20 mM Tris-HCl pH 8, 100 mM NaCl, 7 mM MgCl 2 , 5 mM DTT, 1 mM EDTA and 1 mM NaN 3 . In the hanging-drop vapour-diffusion method, 1 ml protein solution was mixed with 1 ml precipitant solution and equilibrated over a 1 ml reservoir. For microbatch crystallization, 0.3 ml protein solution was mixed with an equal amount of precipitant solution in microbatch 96-well plates and covered with Al's Oil (Hampton Research, USA). device (Oxford Cryosystems; Cosier & Glazer, 1986 ). X-ray data were collected to 3.3 Å resolution on the ID14-1 beamline (ESRF, Grenoble, France). Experiments were carried out at a wavelength of 0.933 Å using an oscillation range of 0.25 and a crystal-to-detector distance of 250 mm. The multiwavelength anomalous dispersion (MAD) data set was also collected at the ESRF (BM14 beamline). The X-ray fluorescence spectra at the Se K absorption edge were measured prior to MAD data collection. Experimental values of the anomalous scattering factors f 0 and f 00 were derived using the CHOOCH program (Evans & Pettifer, 2001) . The data were collected at a high-energy remote wavelength as well as at peak and inflection-point wavelengths chosen according to the fluorescence spectrum.
2.3.2. Crystal form II. X-ray data were collected to 4.2 Å resolution at the ESRF (ID29 beamline) at a wavelength of 0.934 Å using an oscillation range of 0.5 and a crystal-to-detector distance of 320 mm.
2.3.3. Crystal form III. X-ray data were collected to 4.1 Å resolution at the ESRF (ID23-I beamline) at a wavelength of 0.934 Å using an oscillation range of 0.5 and a crystal-to-detector distance of 350 mm.
Data processing
All data sets were processed using the HKL-2000 program suite (Otwinowski & Minor, 1996) . Matthews parameters (Matthews, 1968; Kantardjieff & Rupp, 2003) were calculated using the CCP4 package. 
Figure 2
Self-rotation function plots for hcPheRS crystal form I (space group C2) at sections = 180 (a) and = 90 (b). The SRF map was calculated in the resolution range 40-5 Å with an integration radius of 40 Å ; the maximal value was normalized to 100 and the contours were drawn at 10-unit intervals beginning at 10.
Results and discussion
Three different crystal forms of hcPheRS were detected in the crystallization screens (Fig. 1) and characterized using a synchrotronradiation source at the European Synchrotron Radiation Facility (ESRF, Grenoble, France; see Table 1 for data-collection statistics).
Crystal form I
Well formed crystals were obtained by the hanging-drop method from a solution containing 1.1 M sodium citrate pH 6.5, 0.1 M MES pH 6.5, 5 mM 2-mercaptoethanol and 5 mM DTT. A streak-seeding technique, followed by a number of macroseedings, was used to increase the size of the crystals. These crystals grew to final dimensions of 0.25 Â 0.2 Â 0.15 mm within three weeks and showed the best diffraction limit (to beyond 3.3 Å resolution) of the three crystal forms (see Fig. 1a ). The same crystallization conditions were used to grow the crystals of SeMet derivative of hcPheRS.
Crystal form II
Crystals were grown from 20%(w/v) PEG 3350, 0.1 M bis-Tris propane pH 6.5, 5 mM 2-mercaptoethanol and 5 mM DTT. With macroseeding, these crystals reached final dimensions of 0.4 Â 0.3 Â 0.2 mm within two weeks (Fig. 1b) ; their diffraction characteristics can be found in Table 1 .
Crystal form III
Crystalline aggregates were obtained from 20%(w/v) PEG 3350, 0.1 M bis-Tris propane pH 6.5, 0.3 M sodium malonate, 5 mM 2-mercaptoethanol and 5 mM DTT. These crystalline aggregates were disintegrated for use in macroseeding experiments. After macroseeding, plate-shaped crystals grew in one week to dimensions of 0.4 Â 0.3 Â 0.01 mm (Fig. 1c) .
Molecular replacement studies
The crystallization conditions for crystal forms II and III were first obtained by the microbatch technique and then applied to hanging drops in order to grow the crystals to their final dimensions. Macroseeding for all three crystal forms was performed by lowering the concentration of precipitant by 5%.
Form I crystals of hcPheRS grew in space group C2, with unit-cell parameters a = 362.9, b = 213.6, c = 212.7 Å , = = 90.0, = 125.2 . These crystals were selected for subsequent structure determination (see Table 1 ). V M values for form I crystals ranged between 2.3 and 4.5 Å 3 Da À1 , corresponding to a solvent content of between 45.5 and 72.7%. This suggests that there are M copies of the hcPheRS molecule in an asymmetric unit, where 6 ! M ! 3. However, only peaks corresponding to one fourfold axis and five twofold axes could be clearly seen on the self-rotation function maps. Stereographic projections of the self-rotation map in polar coordinates for = 90 and = 180 are presented in Fig. 2 .
At first glance, the appearance of a fourfold noncrystallographic axis suggests the presence of four molecules in the asymmetric unit related by noncrystallographic symmetry (NCS) elements. Four hcPheRS molecules within an asymmetric unit correspond to a V M value of 3.4 Å 3 Da À1 and a solvent content of 63.3%.
Within the context of the MAD experiments, three data sets (at the peak, the inflection point and a remote wavelength) were collected for crystal form I of selenomethionine-labelled hcPheRS. However, despite the use of various programs (listed in x2.4), we failed to automatically locate the positions of 216 Se atoms in the four molecules within the asymmetric unit. It seems likely that the number of Se atoms, coupled with the strength of the anomalous signal, preclude their automatic identification.
Therefore, molecular replacement was implemented for phase determination. The atomic coordinates of T. thermophilus PheRS (PDB code 1pys; Mosyak et al., 1995) and a -subunit fragment of Pyrococcus horikoshii PheRS (PDB code 2cxi; Sasaki et al., 2006) were used to construct a preliminary model and to carry out an initial search. The model comprised 71.1% of the total number of hcPheRS amino-acid residues; 29% of them share identity with the hcPheRS sequence. All side chains were substituted to serines. We first searched for the positions of () 2 tetramers in the asymmetric unit of the form I crystals. Notably, from the multiple sequence alignment we derived the presence of motif 1 in the amino-acid sequence of hcPheRS. This motif is characterized by a relatively long -helix followed by a -strand and is implicated in the interface formation of dimers and tetramers in class II aaRS. Thus, we believe that the intersubunit interface of hcPheRS will also display the topology of the four-helix bundle observed in the T. thermophilus structure (Mosyak et al., 1995) . Within the asymmetric unit (ASU), the number of tetramers searched varied from one to four (as was to be expected from the self-rotation function). However, we failed to find a solution without steric hindrance. In the next stage of the molecularreplacement search, we used an () heterodimer as the basis of our model. In a similar manner, we varied the number of () heterodimers searched for in the ASU. One of the solutions suggested by the Phaser program (McCoy, 2007) perfectly resembled the () 2 subunit organization of T. thermophilus PheRS. However, despite the apparent similarity between the T. thermophilus tetramer and that found by molecular replacement, differences in the relative orientations of the two heterodimers forming prokaryotic and eukaryotic () 2 molecules were detected.
The changes in the relative orientations of the two heterodimers induced steric clashes between the structural fragments (592-603) related by an intramolecular twofold axis. In the subsequent stages of model rebuilding and refinement, this fragment was removed from the coordinate file. A molecular-replacement search for four modified tetramers in the ASU using the Phaser program provided us with a final high Z score (23.4) solution.
The model obtained from this molecular-replacement search clearly showed that the fourfold axis observed in the rotationfunction map is a pseudo-NCS element. In fact, hcPheRS molecules Pairs of heterodimers located in different tetramers (shown in red and blue) are related by a rotation of 90 , inducing the appearance of a peak at = 90 on the SRF map. crystallize as dimers of two () 2 heterotetramers. Two such dimers are in turn also related by a twofold NCS axis. There is also a twofold intramolecular axis relating the two heterodimers inside the heterotetramers. The combination of all NCS elements in the asymmetric unit generates a fourfold NCS axis, as seen in the SRF map at = 90 (Fig. 3) .
The structure of hcPheRS, in complex with its endogenous ligand phenylalanine, has now been determined by a combination of molecular-replacement and multiwavelength anomalous dispersion methods. The refinement of the human cytoplasmic PheRS structure is currently in progress and will be reported elsewhere.
